中国卒中杂志 ›› 2024, Vol. 19 ›› Issue (1): 94-104.DOI: 10.3969/j.issn.1673-5765.2024.01.013
康志明,梅斌
收稿日期:
2023-04-18
出版日期:
2024-01-20
发布日期:
2024-01-20
通讯作者:
梅斌 neuromei20@163.com
基金资助:
KANG Zhiming, MEI Bin
Received:
2023-04-18
Online:
2024-01-20
Published:
2024-01-20
Contact:
MEI Bin, E-mail: neuromei20@163.com
Supported by:
摘要: 机械取栓是发病24 h内的急性前循环大血管闭塞性缺血性卒中的标准治疗,出血转化是其最常见、最严重的并发症,不仅会延长患者的住院时间,而且会导致预后不良,抵消机械取栓带来的获益。因此,有必要科学地认识这一并发症。近年来,国内外学者围绕机械取栓术后出血转化开展了广泛研究,本文结合国内外文献,从出血转化的定义、分型、发生率、危险因素、预防和管理等方面进行综述。
中图分类号:
康志明, 梅斌. 急性大血管闭塞性卒中机械取栓术后出血转化的研究进展[J]. 中国卒中杂志, 2024, 19(1): 94-104.
KANG Zhiming, MEI Bin. Clinical Advances in Hemorrhagic Transformation after Mechanical Thrombectomy for Acute Ischemic Stroke due to Large Vessel Occlusion[J]. Chinese Journal of Stroke, 2024, 19(1): 94-104.
[1] RENNERT R C,WALI A R,STEINBERG J A,et al. Epidemiology,natural history,and clinical presentation of large vessel ischemic stroke[J/OL]. Neurosurgery,2019,85:S4-S8[2023-03-18]. https://doi.org/10.1093/neuros/nyz042. [2] LAKOMKIN N,DHAMOON M,CARROLL K,et al. Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke:a 10-year systematic review of the literature[J]. J Neurointerv Surg,2019,11(3):241-245. [3] GOYAL M,MENON B K,VAN ZWAM W H,et al. Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials[J]. Lancet,2016,387(100029):1723-1731. [4] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J/OL]. Stroke,2019,50(12):e344-e418[2023-03-19]. https://doi.org/10.1161/STR.0000000000000211. [5] 中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2018[J]. 中国卒中杂志,2018,13(7):706-729. Chinese Stroke Association,Chinese Interventional Neuroradiology Society,Intervention Group of Committee of Stroke Prevention and Control of Chinese Preventive Medicine Association. Chinese guideline for endovascular treatment of acute ischemic stroke 2018[J]. Chin J Stroke,2018,13(7):706-729. [6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682. Chinese Society of Neurology,Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol,2018,51(9):666-682. [7] VAN KRANENDONK K R,TREURNIET K M,BOERS A M M,et al. Hemorrhagic transformation is associated with poor functional outcome in patients with acute ischemic stroke due to a large vessel occlusion[J]. J Neurointerv Surg,2019,11(5):464-468. [8] LEE Y B,YOON W,LEE Y Y,et al. Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions[J]. J Neurointerv Surg,2019,11(5):469-473. [9] KAESMACHER J,KAESMACHER M,MAEGERLEIN C,et al. Hemorrhagic transformations after thrombectomy:risk factors and clinical relevance[J]. Cerebrovasc Dis,2017,43(5/6):294-304. [10] LI W R,XING X L,WEN C,et al. Risk factors and functional outcome were associated with hemorrhagic transformation after mechanical thrombectomy for acute large vessel occlusion stroke[J]. J Neurosurg Sci,2023,67(5):585-590. [11] VON KUMMER R,BRODERICK J P,CAMPBELL B C,et al. The Heidelberg bleeding classification:classification of bleeding events after ischemic stroke and reperfusion therapy[J]. Stroke,2015,46(10):2981-2986. [12] Intracerebral hemorrhage after intravenous t-pa therapy for ischemic stroke[J]. Stroke,1997,28(11):2109-2118. [13] HACKE W,KASTE M,FIESCHI C,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study(ECASS)[J]. JAMA,1995,274(13):1017-1025. [14] HACKE W,KASTE M,BLUHMKI E,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med,2008,359(13):1317-1329. [15] CONSTANT D B P,PRETERRE C,DE GAALON S,et al. Prognosis and risk factors associated with asymptomatic intracranial hemorrhage after endovascular treatment of large vessel occlusion stroke:a prospective multicenter cohort study[J]. Eur J Neurol,2021,28(1):229-237. [16] HAO Y G,LIU W H,WANG H M,et al. Prognosis of asymptomatic intracranial hemorrhage after endovascular treatment[J]. J Neurointerv Surg,2019,11(2):123-126. [17] JIANG F,ZHAO W B,WU C J,et al. Asymptomatic intracerebral hemorrhage may worsen clinical outcomes in acute ischemic stroke patients undergoing thrombectomy[J]. J Stroke Cerebrovasc Dis,2019,28(6):1752-1758. [18] DZIALOWSKI I,PEXMAN J H,BARBER P A,et al. Asymptomatic hemorrhage after thrombolysis may not be benign:prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry[J]. Stroke,2007,38(1):75-79. [19] VAN DER STEEN W,VAN DER ENDE N A M,LUIJTEN S P R,et al. Type of intracranial hemorrhage after endovascular stroke treatment:association with functional outcome[J]. J Neurointerv Surg,2023,15(10):971-976. [20] FELDMAN M J,ROTH S,FUSCO M R,et al. Association of asymptomatic hemorrhage after endovascular stroke treatment with outcomes[J]. J Neurointerv Surg,2021,13(12):1095-1098. [21] MARTINS S O,MONT’ALVERNE F,REBELLO L C,et al. Thrombectomy for stroke in the public health care system of Brazil[J]. N Engl J Med,2020,382(24):2316-2326. [22] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med,2018,378(1):11-21. [23] ALBERS G W,MARKS M P,KEMP S,et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718. [24] JOVIN T G,NOGUEIRA R G,LANSBERG M G,et al. Thrombectomy for anterior circulation stroke beyond 6 h from time last known well(AURORA):a systematic review and individual patient data meta-analysis[J]. Lancet,2022,399(10321):249-258. [25] ZI W J,WANG H M,YANG D,et al. Clinical effectiveness and safety outcomes of endovascular treatment for acute anterior circulation ischemic stroke in China[J]. Cerebrovasc Dis,2017,44(5/6):248-258. [26] CAI L X,YU X B,YU J,et al. Can tirofiban improve the outcome of patients with acute ischemic stroke:a propensity score matching analysis[J/OL]. Front Neurol,2021,12:688019[2023-03-11]. https://doi.org/10.3389/fneur.2021.688019. [27] KINJO N,YOSHIMURA S,UCHIDA K,et al. Incidence and prognostic impact of intracranial hemorrhage after endovascular treatment for acute large vessel occlusion[J]. Cerebrovasc Dis,2020,49(5):540-549. [28] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性脑梗死后出血转化诊治共识2019[J]. 中华神经科杂志,2019,52(4):252-265. Chinese Society of Neurology,Chinese Stroke Society. Consensus on diagnosis and treatment of hemorrhagic transformation after acute ischemic stroke in China 2019[J]. Chin J Neurol,2019,52(4):252-265. [29] YOSHIMURA S,SAKAI N,YAMAGAMI H,et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med,2022,386(14):1303-1313. [30] CAPPELLARI M,MANGIAFICO S,SAIA V,et al. IER-SICH nomogram to predict symptomatic intracerebral hemorrhage after thrombectomy for stroke[J]. Stroke,2019,50(4):909-916. [31] SUN J C,LAM C,CHRISTIE L,et al. Risk factors of hemorrhagic transformation in acute ischaemic stroke:a systematic review and meta-analysis [J/OL]. Front Neurol,2023,14:1079205[2023-03-11]. https://doi.org/10.3389/fneur.2023.1079205. [32] JIANG S W,FEI A H,PENG Y,et al. Predictors of outcome and hemorrhage in patients undergoing endovascular therapy with solitaire stent for acute ischemic stroke[J/OL]. PLoS One,2015,10(12):e144452[2023-03-11]. https://doi.org/10.1371/journal.pone.0144452. [33] HAO Z L,YANG C S,XIANG L B,et al. Risk factors for intracranial hemorrhage after mechanical thrombectomy:a systematic review and meta-analysis[J]. Expert Rev Neurother,2019,19(10):927-935. [34] JIMENEZ-CONDE J,BIFFI A,RAHMAN R,et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke[J]. Stroke,2010,41(3):437-442. [35] D’AMELIO M,TERRUSO V,FAMOSO G,et al. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke[J]. Cerebrovasc Dis,2011,32(3):234-238. [36] YERAMANENI S,KLEINDORFER D O,SUCHAREW H,et al. Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use:a population-based study[J]. Int J Stroke,2017,12(2):152-160. [37] SUGIURA Y,YAMAGAMI H,SAKAI N,et al. Predictors of symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke with large vessel occlusion[J]. J Stroke Cerebrovasc Dis,2017,26(4):766-771. [38] VENDITTI L,CHASSIN O,ANCELET C,et al. Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke[J]. J Neurol,2021,268(5):1867-1875. [39] GOYAL N,TSIVGOULIS G,PANDHI A,et al. Admission hyperglycemia and outcomes in large vessel occlusion strokes treated with mechanical thrombectomy[J]. J Neurointerv Surg,2018,10(2):112-117. [40] ZANG L,ZHANG D,YAO Y Y,et al. Symptomatic intracranial hemorrhage in patients with admission hyperglycemia and diabetes after mechanical thrombectomy:a systematic review and meta-analysis [J/OL]. Am J Emerg Med,2021,45:23-28[2023-03-11]. https://doi.org/10.1016/j.ajem.2021.02.032. [41] CHIU C D,CHEN C C,SHEN C C,et al. Hyperglycemia exacerbates intracerebral hemorrhage via the downregulation of aquaporin-4:temporal assessment with magnetic resonance imaging[J]. Stroke,2013,44(6):1682-1689. [42] DIETRICH W D,ALONSO O,BUSTO R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats[J]. Stroke,1993,24(1):111-116. [43] BARBER P A,DEMCHUK A M,ZHANG J,et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy[J]. Lancet,2000,355(9216):1670-1674. [44] HAO Y G,YANG D,WANG H M,et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke[J]. Stroke,2017,48(5):1203-1209. [45] DEMEESTERE J,GARCIA-ESPERON C,GARCIA-BERMEJO P,et al. Evaluation of hyperacute infarct volume using ASPECTS and brain CT perfusion core volume[J]. Neurology,2017,88(24):2248-2253. [46] BANG O Y,SAVER J L,KIM S J,et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke[J]. Stroke,2011,42(8):2235-2239. [47] QIAN J C,FAN L,ZHANG W Q,et al. A meta-analysis of collateral status and outcomes of mechanical thrombectomy[J]. Acta Neurol Scand,2020,142(3):191-199. [48] PUETZ V,DZIALOWSKI I,HILL M D,et al. Intracranial thrombus extent predicts clinical outcome,final infarct size and hemorrhagic transformation in ischemic stroke:the clot burden score[J]. Int J Stroke,2008,3(4):230-236. [49] YOGENDRAKUMAR V,AL-AJLAN F,NAJM M,et al. Clot burden score and early ischemia predict intracranial hemorrhage following endovascular therapy[J]. AJNR Am J Neuroradiol,2019,40(4):655-660. [50] MAIR G,BOYD E V,CHAPPELL F M,et al. Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic stroke[J]. Stroke,2015,46(1):102-107. [51] KANG Z M,WU L S,SUN D,et al. Proximal hyperdense middle cerebral artery sign is associated with increased risk of asymptomatic hemorrhagic transformation after endovascular thrombectomy:a multicenter retrospective study[J]. J Neurol,2023,270(3):1587-1599. [52] RENÚ A,LAREDO C,TUDELA R,et al. Brain hemorrhage after endovascular reperfusion therapy of ischemic stroke:a threshold-finding whole-brain perfusion CT study[J]. J Cereb Blood Flow Metab,2017,37(1):153-165. [53] KAMEDA K,UNO J,OTSUJI R,et al. Optimal thresholds for ischemic penumbra predicted by computed tomography perfusion in patients with acute ischemic stroke treated with mechanical thrombectomy[J]. J Neurointerv Surg,2018,10(3):279-284. [54] JIANG L,ZHOU L L,ZHANG H,et al. MRI predictors of intracranial hemorrhage in acute ischemic stroke after endovascular thrombectomy therapy[J]. Am J Transl Res,2020,12(8):4532-4541. [55] EMBERSON J,LEES K R,LYDEN P,et al. Effect of treatment delay,age,and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke:a meta-analysis of individual patient data from randomised trials[J]. Lancet,2014,384(9958):1929-1935. [56] SUMII T,LO E H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats[J]. Stroke,2002,33(3):831-836. [57] LAKHAN S E,KIRCHGESSNER A,TEPPER D,et al. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke[J/OL]. Front Neurol,2013,4:32[2023-03-11]. https://doi.org/10.3389/fneur.2013.00032. [58] PODLASEK A,DHILLON P S,BUTT W,et al. Direct mechanical thrombectomy without intravenous thrombolysis versus bridging therapy for acute ischemic stroke:a meta-analysis of randomized controlled trials[J]. Int J Stroke,2021,16(6):621-631. [59] ZHENG M L,LI L,CHEN L Z,et al. Mechanical thrombectomy combined with intravenous thrombolysis for acute ischemic stroke:a systematic review and meta-analyses[J/OL]. Sci Rep,2023,13(1):8597[2023-03-11]. https://doi.org/10.1038/s41598-023-35532-7. [60] COUTURE M,MARNAT G,GRIFFIER R,et al. Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy[J]. Acta Neurol Scand,2021,144(5):500-508. [61] VAN DE GRAAF R A,ZINKSTOK S M,CHALOS V,et al. Prior antiplatelet therapy in patients undergoing endovascular treatment for acute ischemic stroke:results from the MR CLEAN registry[J]. Int J Stroke,2020,16(4):476-485. [62] MEINEL T R,KNIEPERT J U,SEIFFGE D J,et al. Endovascular stroke treatment and risk of intracranial hemorrhage in anticoagulated patients[J]. Stroke,2020,51(3):892-898. [63] RAMOS-ARAQUE M E,CHAVARRÍA-MIRANDA A,GÓMEZ-VICENTE B,et al. Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy:data from the Nordictus registry [J/OL]. Front Neurol,2020,11:594251[2023-03-11]. https://doi.org/10.3389/fneur.2020.594251. [64] L’ALLINEC V,ERNST M,SEVIN-ALLOUET M,et al. Safety and efficacy of mechanical thrombectomy in acute ischemic stroke of anticoagulated patients[J/OL]. J Neurointerv Surg,2018,10(12):e29[2023-03-11]. https://doi.org/10.1136/neurintsurg-2017-013714. [65] PURRUCKER J C,WOLF M,HAAS K,et al. Safety of endovascular thrombectomy in patients receiving non-vitamin K antagonist oral anticoagulants[J]. Stroke,2016,47(4):1127-1130. [66] GOLDHOORN R B,VAN DE GRAAF R A,VAN REES J M,et al. Endovascular treatment for acute ischemic stroke in patients on oral anticoagulants:results from the MR CLEAN registry[J]. Stroke,2020,51(6):1781-1789. [67] LAPERGUE B,BLANC R,GORY B,et al. Effect of endovascular contact aspiration vs. stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion:the ASTER randomized clinical trial[J]. JAMA,2017,318(5):443-452. [68] LAPERGUE B,BLANC R,COSTALAT V,et al. Effect of thrombectomy with combined contact aspiration and stent retriever vs. stent retriever alone on revascularization in patients with acute ischemic stroke and large vessel occlusion:the ASTER2 randomized clinical trial[J]. JAMA,2021,326(12):1158-1169. [69] MOHAMMADEN M H,HAUSSEN D C,PISANI L,et al. Stent-retriever alone vs. aspiration and stent-retriever combination in large vessel occlusion stroke:a matched analysis[J]. Int J Stroke,2022,17(4):465-473. [70] BRODERICK J P,PALESCH Y Y,DEMCHUK A M,et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med,2013,368(10):893-903. [71] ZHAO W B,CHE R W,SHANG S Y,et al. Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy[J]. Stroke,2017,48(12):3289-3294. [72] PAN X,ZHENG D,ZHENG Y,et al. Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke[J]. Eur J Neurol,2019,26(8):1105-1110. [73] CHANG Y,KIM B M,BANG O Y,et al. Rescue stenting for failed mechanical thrombectomy in acute ischemic stroke:a multicenter experience[J]. Stroke,2018,49(4):958-964. [74] MOHAMMADEN M H,HAUSSEN D C,AL-BAYATI A R,et al. Stenting and angioplasty in neurothrombectomy:matched analysis of rescue intracranial stenting versus failed thrombectomy[J]. Stroke,2022,53(9):2779-2788. [75] MONTALVO M,MISTRY E,CHANG A D,et al. Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy:the TAG score[J]. J Neurol Neurosurg Psychiatry,2019,90(12):1370-1374. [76] MISTRY E A,MISTRY A M,NAKAWAH M O,et al. Systolic blood pressure within 24 hours after thrombectomy for acute ischemic stroke correlates with outcome [J/OL]. J Am Heart Assoc,2017,6(5):e006167[2023- 03-11]. https://doi.org/10.1161/JAHA.117.006167. [77] ANADANI M,ORABI M Y,ALAWIEH A,et al. Blood pressure and outcome after mechanical thrombectomy with successful revascularization[J]. Stroke,2019,50(9):2448-2454. [78] KATSANOS A H,MALHOTRA K,AHMED N,et al. Blood pressure after endovascular thrombectomy and outcomes in patients with acute ischemic stroke:an individual patient data meta-analysis[J/OL]. Neurology,2022,98(3):e291-e301[2023-03-11]. https://doi.org/10.1212/WNL.0000000000013049. [79] PETERSEN N H,KODALI S,MENG C,et al. Blood pressure trajectory groups and outcome after endovascular thrombectomy:a multicenter study[J]. Stroke,2022,53(4):1216-1225. [80] ANADANI M,ARTHUR A S,TSIVGOULIS G,et al. Blood pressure goals and clinical outcomes after successful endovascular therapy:a multicenter study[J]. Ann Neurol,2020,87(6):830-839. [81] MAZIGHI M,RICHARD S,LAPERGUE B,et al. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke(BP-TARGET):a multicentre,open-label,randomised controlled trial[J]. Lancet Neurol,2021,20(4):265-274. [82] YANG P F,SONG L L,ZHANG Y W,et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke(ENCHANTED2/MT):a multicentre,open-label,blinded-endpoint,randomised controlled trial[J]. Lancet,2022,400(10367):1585-1596. [83] ZHANG X H,XIE Y,WANG H M,et al. Symptomatic intracranial hemorrhage after mechanical thrombectomy in Chinese ischemic stroke patients:the ASIAN score[J]. Stroke,2020,51(9):2690-2696. |
[1] | 曹黎明, 任力杰. 急性缺血性卒中诊疗技术的进展与展望[J]. 中国卒中杂志, 2024, 19(9): 983-989. |
[2] | 符鹏程, 曹黎明, 朱佳倩, 赵桂玉, 徐格林. 大动脉粥样硬化性缺血性卒中再灌注治疗的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1004-1011. |
[3] | 张丽苹, 曹黎明, 肖楠, 廖雨琦, 池枫, 余艳妮, 任力杰. 纳米材料在缺血性卒中诊疗中的研究进展及挑战[J]. 中国卒中杂志, 2024, 19(9): 1012-1017. |
[4] | 王晓蕊, 骆嵩, 邹良玉, 屈洪党, 崔雪, 赵玉洁. 嗜酸性粒细胞与单核细胞比值预测急性缺血性卒中患者静脉溶栓预后的价值研究 [J]. 中国卒中杂志, 2024, 19(9): 1025-1033. |
[5] | 王铄, 余苹, 张宁, 王春雪. 2013—2023年缺血性卒中与睡眠相关性研究的文献计量学分析 [J]. 中国卒中杂志, 2024, 19(9): 1040-1047. |
[6] | 周宏宇, 李子孝, 王拥军. 基于影像组学预测大脑年龄与缺血性卒中的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1066-1076. |
[7] | 阿娜古丽·阿不拉尼压孜, 吴晓欣, 李骄星, 李竹浩, 盛文利. 急性缺血性卒中磁敏感血管征影响因素及临床应用的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1077-1085. |
[8] | 杨金波, 张聪. 高分辨率血管壁成像在缺血性卒中患者中的应用进展[J]. 中国卒中杂志, 2024, 19(9): 1086-1093. |
[9] | 吴春艳, 尹雅诗, 王广志, 岳奎涛. 急性缺血性卒中不同时间窗影像学评价及应用进展[J]. 中国卒中杂志, 2024, 19(9): 1094-1101. |
[10] | 张梦若, 徐守臣, 隋翠翠, 李玉奎, 王雪莉. 下肢康复机器人联合头针治疗对老年缺血性卒中患者步行效率和协调功能影响调查 [J]. 中国卒中杂志, 2024, 19(8): 902-908. |
[11] | 吴娱倩, 张玉梅, 臧大维, 范小伟, 王安心, 张晓丽, 孟霞. 上肢动作研究测试量表评定亚急性期缺血性卒中患者偏瘫侧上肢及手功能的信效度和敏感性研究 [J]. 中国卒中杂志, 2024, 19(8): 915-923. |
[12] | 莫秋红, 丁晓波, 李靓, 张岩波, 李伟荣. 基于可解释性机器学习模型的轻型缺血性卒中复发预测研究[J]. 中国卒中杂志, 2024, 19(8): 924-930. |
[13] | 逯丹, 陈玮琪, 王雅平, 段婉莹, 郭蕾, 王玲, 刘丽萍, 徐安定, 王拥军, 中国卒中学会脑保护圆桌会学术委员会. 缺血性卒中脑细胞保护科学声明——来自中国卒中学会的科学声明 [J]. 中国卒中杂志, 2024, 19(8): 938-955. |
[14] | 李光硕, 赵性泉. 《中国急性缺血性卒中诊治指南2023》解读[J]. 中国卒中杂志, 2024, 19(8): 956-961. |
[15] | 白磊鹏, 罗杰, 周思捷, 黄健辉, 梁铭钦, 赵庆顺. 肺叶楔形切除术后并发急性缺血性卒中行介入取栓治疗2例并文献回顾 [J]. 中国卒中杂志, 2024, 19(8): 962-966. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||